Compare ELUT & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELUT | UG |
|---|---|---|
| Founded | 2015 | 1942 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.3M | 27.7M |
| IPO Year | 2020 | N/A |
| Metric | ELUT | UG |
|---|---|---|
| Price | $0.95 | $6.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 476.9K | 10.2K |
| Earning Date | 03-05-2026 | 11-06-2025 |
| Dividend Yield | N/A | ★ 10.72% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | ★ $21,746,000.00 | $10,060,322.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $15.31 |
| Revenue Growth | ★ 24.08 | N/A |
| 52 Week Low | $0.50 | $5.58 |
| 52 Week High | $3.46 | $11.98 |
| Indicator | ELUT | UG |
|---|---|---|
| Relative Strength Index (RSI) | 71.32 | 59.12 |
| Support Level | $0.74 | $6.16 |
| Resistance Level | $0.91 | $6.74 |
| Average True Range (ATR) | 0.09 | 0.14 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 97.43 | 60.29 |
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.